Product Information

AMLODIPINE-OLMESARTAN 5-40 MG is a generic product labeled by Micro Labs Limited, priced at $0.3122 per EA under NDC 42571023730. Its NADAC has been published 402 times since Dec 12, 2018.

FDA first approved this application on Nov 2, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-OLMESARTAN 5-40 MG

Amlodipine and Olmesartan Medoxomil
$0.3122per EA

Strength

5; 40 mg/1; mg/1

Manufacturer

Micro Labs Limited

NDC

42571023730

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207435

FDA Approved

11/2/2017

TE Code

AB

On Market Since

1/1/2018

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has been published 402 times since Dec 12, 2018, and over the history we have for it it has declined 55.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3122 per EA
All-time high$0.9091 (Jun 10, 2020)
All-time low$0.2762 (Apr 22, 2026)
52-week high$0.3755
52-week low$0.2762
Median price$0.4246
Average price$0.4833
Largest weekly change-45.3% (Nov 18, 2020)
Weeks tracked402
Tracking sinceDec 12, 2018

Price History

1W

+3.1%

1M

+3.1%

3M

+9.6%

6M

+9.9%

1Y

-16.8%

3Y

-16.4%

5Y

-17.6%

All

-55.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 5-40 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-40 MG, manufactured by Micro Labs Limited, is $0.3122 per EA (NDC 42571023730), effective Aug 19, 2026.

How has the price of AMLODIPINE-OLMESARTAN 5-40 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has declined 55.1%. It has been tracked across 402 weekly CMS publications since Dec 12, 2018.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-40 MG?

Since Dec 12, 2018, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has ranged from a low of $0.2762 (Apr 22, 2026) to a high of $0.9091 (Jun 10, 2020), with a median of $0.4246 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-40 MG?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-OLMESARTAN 5-40 MG, is $0.2788 per EA — about 11% below AMLODIPINE-OLMESARTAN 5-40 MG.

Who manufactures AMLODIPINE-OLMESARTAN 5-40 MG?

AMLODIPINE-OLMESARTAN 5-40 MG (NDC 42571023730) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.